GAIN THERAPEUTICS, INC Investment Income, Nonoperating
GAIN THERAPEUTICS, INC (GANX) reported Investment Income, Nonoperating of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNonoperating · last filed 2026-03-26
- GAIN THERAPEUTICS, INC investment income, nonoperating for the quarter ending 2024-12-31 was $0.00.
- GAIN THERAPEUTICS, INC investment income, nonoperating for the quarter ending 2024-09-30 was $0.00.
- GAIN THERAPEUTICS, INC investment income, nonoperating for the quarter ending 2024-06-30 was $4.00K.
- GAIN THERAPEUTICS, INC investment income, nonoperating for the quarter ending 2024-03-31 was $34.00K.
- GAIN THERAPEUTICS, INC investment income, nonoperating for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- GAIN THERAPEUTICS, INC investment income, nonoperating for fiscal 2024 was $38.00K.
| Period end | Investment Income, Nonoperating 3 month | Investment Income, Nonoperating 6 month | Investment Income, Nonoperating 9 month | Investment Income, Nonoperating 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-26 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $4.00K derived: sum of 3 quarters · filed 2026-03-26 | $38.00K 10-K · filed 2026-03-26 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | $4.00K derived: sum of 2 quarters · filed 2025-11-12 | $38.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $4.00K 10-Q · filed 2025-08-12 | $38.00K 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | $34.00K 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |